Spruce Street Capital LP

Q3 2026 13F-HR Holdings

Location
New York, NY
Holdings as of
9/30/2026
Date filed
11/13/2026
Form type
13F-HR
Num holdings
39
Total value ($000)
$628,984
Net value change ($000)
+119,303 (23.4%)
New positions
9
Sold out positions
0
Turnover %
16.3%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ENTXW 32,631 NEW
ZLAB 22,147 417.6%
OBSIDIAN THERAPEUTICS INC 17,162 NEW
SGMT 13,832 NEW
YARROW BIOSCIENCE INC 13,678 NEW
KORSANA BIOSCIENCES INC 10,304 NEW
ALKERMES PLC 9,936 34.9%
KNSA 9,786 16.7%
LBRX 9,200 20.6%
ANRO 7,096 19.9%
Top Reduces (Value $000, Stocks/ETFs)
RLMD -18,169 -41.1%
ALMS -8,146 -73.7%
NERV -3,642 -39.6%
DNTH -3,345 -9.7%
IPSC -3,004 -30.2%
CATX -2,438 -19.4%
LONA -2,212 -61.1%
RLAY -1,970 -3.5%
ELVN -1,615 -9.7%
SABS -1,605 -18.7%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type